Trial Profile
Dapagliflozin effects on the kinetics of lipoproteins in patients with diabetes type 2
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Feb 2024
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms Cinetique DAPA
- 22 Feb 2024 Status changed from recruiting to completed.
- 19 Nov 2019 Planned number of patients changed from 26 to 28.
- 19 Nov 2019 Planned End Date changed from 1 Mar 2019 to 1 Jun 2021.